NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors by Wang-Gillam, Andrea, Hubner, Richard A., Siveke, Jens T., Von Hoff, Daniel D., Belanger, Bruce, de Jong, Floris A., Mirakhur, Beloo, Chen, Li-Tzong

Get full text

The role of cancer nurses in cancer-related pain management in Europe by de Munter, Johan, Dodlek, Nikolina, Khmaladze, Ani, Parreira, Sara Torcato, Ullgren, Helena, de Man, Rik, de Jong, Floris A., Oldenmenger, Wendy H.

Get full text

A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients by EECHOUTE, Karel, FRANSSON, Martin N, LOOS, Walter J, MATHIJSSEN, Ron H. J, DE GIORGI, Ugo, REYNERS, An K, DE JONG, Floris A, SPARREBOOML, Alex, VAN DER GRAAF, Winette T. A, FRIBERG, Lena E, SCHIAVON, Gaia, WIEMER, Erik A. C, VERWEIJ, Jaap

Get full text

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer by Chen, Li-Tzong, Macarulla, Teresa, Blanc, Jean-Frédéric, Mirakhur, Beloo, Jong, Floris A de, Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T

Get full text

Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence by Tascilar, Metin, de Jong, Floris A., Verweij, Jaap, Mathijssen, Ron H. J.

Get full text

A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan by van der Bol, Jessica M, Mathijssen, Ron H J, Creemers, Geert-Jan M, Planting, André S Th, Loos, Walter J, Wiemer, Erik A C, Friberg, Lena E, Verweij, Jaap, Sparreboom, Alex, de Jong, Floris A

Get full text

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours by Mahalingam, Devalingam, Patel, Manish R., Sachdev, Jasgit C., Hart, Lowell L., Halama, Niels, Ramanathan, Ramesh K., Sarantopoulos, John, Völkel, Dirk, Youssef, Ashraf, Jong, Floris A., Tsimberidou, Apostolia Maria

Get full text

Role of pharmacogenetics in irinotecan therapy by de Jong, Floris A., de Jonge, Maja J.A., Verweij, Jaap, Mathijssen, Ron H.J.

Get full text

Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin by Hubner, Richard A., Cubillo, Antonio, Blanc, Jean-Frédéric, Melisi, Davide, Von Hoff, Daniel D., Wang-Gillam, Andrea, Chen, Li-Tzong, Becker, Claus, Mamlouk, Khalid, Belanger, Bruce, Yang, Yoojung, de Jong, Floris A., Siveke, Jens T.

Get full text

Management of fatigue in patients with cancer – A practical overview by Koornstra, Rutger H.T, Peters, Marlies, Donofrio, Stacey, van den Borne, Ben, de Jong, Floris A

Get full text

Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents by Joerger, Markus, Koster, Kira-Lee, Janik, Tomas, de Jong, Floris A

Get full text

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study by van der Bol, Jessica M, Loos, Walter J, de Jong, Floris A, van Meerten, Esther, Konings, Inge R.H.M, Lam, Mei H, de Bruijn, Peter, Wiemer, Erik A.C, Verweij, Jaap, Mathijssen, Ron H.J

Get full text

Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature by Hamberg, Paul, De Jong, Floris A., Brandsma, Dieta, Verweij, Jaap, Sleijfer, Stefan

Get full text

Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of... by Chen, Li-Tzong, Macarulla, Teresa, Blanc, Jean-Frédéric, Mirakhur, Beloo, de Jong, Floris A., Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T.

Get full text

Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: E... by Chen, Li-Tzong, Siveke, Jens T., Wang-Gillam, Andrea, Li, Chung-Pin, Bodoky, György, Dean, Andrew P., Shan, Yan-Shen, Jameson, Gayle S., Macarulla, Teresa, Lee, Kyung-Hun, Cunningham, David, Blanc, Jean-Frédéric, Chiu, Chang-Fang, Schwartsmann, Gilberto, Braiteh, Fadi S., Mamlouk, Khalid, Belanger, Bruce, de Jong, Floris A., Hubner, Richard A.

Get full text

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST an... by Pelzer, Uwe, Blanc, Jean-Frédéric, Melisi, Davide, Cubillo, Antonio, Von Hoff, Daniel D, Wang-Gillam, Andrea, Chen, Li-Tzong, Siveke, Jens T, Wan, Yin, Solem, Caitlyn T, Botteman, Marc F, Yang, Yoojung, de Jong, Floris A, Hubner, Richard A

Get full text

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial by Macarulla, Teresa, Blanc, Jean-Frédéric, Wang-Gillam, Andrea, Chen, Li-Tzong, Siveke, Jens T., Mirakhur, Beloo, Chen, Jie, de Jong, Floris A.

Get full text

Post-gemcitabine therapy for patients with advanced pancreatic cancer – a comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens by Vogel, Arndt, Ciardiello, Fortunato, Hubner, Richard A, Blanc, Jean-Frédéric, Carrato, Alfredo, Yang, Yoojung, Patel, Dipen A, Ektare, Varun, de Jong, Floris A, Gill, Sharlene

Get full text

ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition by DE JONG, Floris A, MARSH, Sharon, MATHIJSSEN, Ron H. J, KING, Cristi, VERWEIJ, Jaap, SPARREBOOM, Alex, MCLEOD, Howard L

Get full text

Flat‐Fixed Dosing Versus Body Surface Area–Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference? by Mathijssen, Ron H.J., de Jong, Floris A., Loos, Walter J., van der Bol, Jessica M., Verweij, Jaap, Sparreboom, Alex

Get full text